APOE and Alzheimer disease: In summary, MOFA provided further evidence for non-myelinating oligodendrocytes (Oligo.3-5 subclusters, Figure 5) as vulnerable in APOE E4+ carriers and identified additional genes previously implicated in AD in these cell types and associated WM.